What is the ticker symbol for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals trades under the ticker MDGL on NASDAQ.

What sector does Madrigal Pharmaceuticals operate in?

Madrigal Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MDGL in a portfolio?

PortView shows MDGL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Madrigal Pharmaceuticals (MDGL) Stock Analysis

NASDAQHealthcareBiotechnology

$540.88+0.40%

1-year price historyRange $412.35 – $602.83

52-week range$540.88

$393.61$615.00

What Madrigal Pharmaceuticals does

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.

Key metrics

Market cap

$12.50B

P/E (TTM)

-42.26

EPS (TTM)

$-12.80

Beta

-1.00

Dividend yield

0.00%

Revenue / share

$44.05

50-day avg

$527.72

200-day avg

$515.13

52-week high

$615.00

52-week low

$393.61

CEO

William J. Sibold

ETFs linked to MDGL

Broad-market and Healthcare sector ETFs an investor holding Madrigal Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MDGL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MDGL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals trades under the ticker MDGL on NASDAQ.
Which exchange is MDGL listed on?: MDGL is listed on NASDAQ.
What sector does Madrigal Pharmaceuticals operate in?: Madrigal Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MDGL in a portfolio?: PortView shows MDGL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.